Sign in
Taking people in SwedenPhase 1/2

Tests a treatment in people with kidney cancer and kidney failure

Tests a treatment in adults with spreading kidney cancer and end-stage kidney disease.

Key facts

Who runs it
Oncorena AB
Where
Solna, SwedenSee the siteAlso in 3 other countries, 4 sites
Registry title
Kidney cancer
Status
Recruiting
Phase
Phase 1/2
People taking part
105 people, planned
Started
24 Apr 2024
Expected to end
31 Jan 2029
Type of study
Interventional
Record updated
15 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with metastatic kidney cancer (clear cell or papillary type) who also have end-stage kidney disease.

Age
18 years or older
Sex
All sexes can join
Disease stage
Metastatic clear cell renal cell carcinoma or papillary renal cell carcinoma, together with end-stage renal disease

Where in Sweden

Also in 3 other countries, 4 sites

  • Karolinska University HospitalSolna, SwedenTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Tests a treatment in people with kidney cancer and kidney failureGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
15 September 2026